Chargement en cours...
Lenalidomide Desensitization in Systemic Light-Chain Amyloidosis With Multi-Organ Involvement
Limited therapeutic options are available to amyloid patients treated with many lines of therapy. Although combination therapy using lenalidomide and dexamethasone is an effective sequential regimen for systemic amyloidosis (AL), dexamethasone is often poorly tolerated in patients with cardiac invol...
Enregistré dans:
| Publié dans: | J Clin Med Res |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Elmer Press
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4554222/ https://ncbi.nlm.nih.gov/pubmed/26346623 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jocmr2303e |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|